Clinical trials Cancer Research UK
More than one in five adult cancer patients in the UK take part in a clinical trial – a higher proportion than anywhere else in the world. More than 33, 000 of them are on a clinical study funded by us, and we support more than seven out of 10 of the UK’s child and young adult cancer trials.
Our clinical trials cover a wide range of treatments including radiotherapy, immunotherapy and chemotherapy, as well as cancer prevention, early diagnosis and screening.
We fund clinical trials finding better ways to treat many different types of cancer, from the most common – such as breast, bowel, prostate and lung cancer – to rare cancers, through our International Rare Cancers Initiative.
We have seven clinical trials units, designing and co-ordinating large-scale studies across the whole of the UK. Our Children’s Cancer Trials Team, headed by Professor Pam Kearns, co-ordinates groundbreaking trials at 21 centres across the UK and Ireland.
How we’ve made a difference so far
Here are just a few examples of how we...
- Have taken over 100 new drugs into clinical trials since the early 1980s - more than 100, 000 patients have joined our treatment trials since 1995
- Funded major trials for pancreatic cancer, changing the way that patients are treated and bringing them precious extra time.
Call to step up the pace of TB-HIV collaborative activities — Weekly Blitz
Discovery by biomedical research of new and improved interventions can get into the bucket of implementation.
|
Super Bio-Enteric Curcumin w Bioperine-Bromelain 800 mg-100 Tabs ENTERIC COATED 5X Absorption Health and Beauty (Physician Naturals)
|
Popular Q&A
Does the hospital conduct clinical trials or basic research related
to cancer?
The Cleveland Clinic Cancer Center belongs to four of the largest cooperative study groups in the country: the Southwestern Cooperative Oncology Group, the National Surgical Adjuvant Breast and Bowel Project, the Gynecological Oncology Group and the Children's Cancer Study Group. These groups study relatively rare cancers as well as expedite the testing of promising new therapies for common cancers. The Cancer Center's participation in these groups assures patients access to a wide variety of promising treatments through clinical trials. Numerous research protocols in progress at the Cl…
